Treatment of Stat3 inhibitor WP1066 in B16-F10 tumor cells inoculated wild-type mice resulted in reduced proliferating cells, decreased blood vessels, and low percentage of CD11b+Gr-1+ MDSCs. Here, STAT3 is linked to neoplasm.